Global Antidiabetic Thiazolidinediones Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Antidiabetic Thiazolidinediones Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Antidiabetic Thiazolidinediones by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Antidiabetic Thiazolidinediones by Country/Region, 2017, 2022 & 2028

2.2 Antidiabetic Thiazolidinediones Segment by Type

2.2.1 Rosiglitazone

2.2.2 Pioglitazone

2.3 Antidiabetic Thiazolidinediones Sales by Type

2.3.1 Global Antidiabetic Thiazolidinediones Sales Market Share by Type (2017-2022)

2.3.2 Global Antidiabetic Thiazolidinediones Revenue and Market Share by Type (2017-2022)

2.3.3 Global Antidiabetic Thiazolidinediones Sale Price by Type (2017-2022)

2.4 Antidiabetic Thiazolidinediones Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Other

2.5 Antidiabetic Thiazolidinediones Sales by Application

2.5.1 Global Antidiabetic Thiazolidinediones Sale Market Share by Application (2017-2022)

2.5.2 Global Antidiabetic Thiazolidinediones Revenue and Market Share by Application (2017-2022)

2.5.3 Global Antidiabetic Thiazolidinediones Sale Price by Application (2017-2022)

3 Global Antidiabetic Thiazolidinediones by Company

3.1 Global Antidiabetic Thiazolidinediones Breakdown Data by Company

3.1.1 Global Antidiabetic Thiazolidinediones Annual Sales by Company (2020-2022)

3.1.2 Global Antidiabetic Thiazolidinediones Sales Market Share by Company (2020-2022)

3.2 Global Antidiabetic Thiazolidinediones Annual Revenue by Company (2020-2022)

3.2.1 Global Antidiabetic Thiazolidinediones Revenue by Company (2020-2022)

3.2.2 Global Antidiabetic Thiazolidinediones Revenue Market Share by Company (2020-2022)

3.3 Global Antidiabetic Thiazolidinediones Sale Price by Company

3.4 Key Manufacturers Antidiabetic Thiazolidinediones Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Antidiabetic Thiazolidinediones Product Location Distribution

3.4.2 Players Antidiabetic Thiazolidinediones Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Antidiabetic Thiazolidinediones by Geographic Region

4.1 World Historic Antidiabetic Thiazolidinediones Market Size by Geographic Region (2017-2022)

4.1.1 Global Antidiabetic Thiazolidinediones Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Antidiabetic Thiazolidinediones Annual Revenue by Geographic Region

4.2 World Historic Antidiabetic Thiazolidinediones Market Size by Country/Region (2017-2022)

4.2.1 Global Antidiabetic Thiazolidinediones Annual Sales by Country/Region (2017-2022)

4.2.2 Global Antidiabetic Thiazolidinediones Annual Revenue by Country/Region

4.3 Americas Antidiabetic Thiazolidinediones Sales Growth

4.4 APAC Antidiabetic Thiazolidinediones Sales Growth

4.5 Europe Antidiabetic Thiazolidinediones Sales Growth

4.6 Middle East & Africa Antidiabetic Thiazolidinediones Sales Growth

5 Americas

5.1 Americas Antidiabetic Thiazolidinediones Sales by Country

5.1.1 Americas Antidiabetic Thiazolidinediones Sales by Country (2017-2022)

5.1.2 Americas Antidiabetic Thiazolidinediones Revenue by Country (2017-2022)

5.2 Americas Antidiabetic Thiazolidinediones Sales by Type

5.3 Americas Antidiabetic Thiazolidinediones Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Antidiabetic Thiazolidinediones Sales by Region

6.1.1 APAC Antidiabetic Thiazolidinediones Sales by Region (2017-2022)

6.1.2 APAC Antidiabetic Thiazolidinediones Revenue by Region (2017-2022)

6.2 APAC Antidiabetic Thiazolidinediones Sales by Type

6.3 APAC Antidiabetic Thiazolidinediones Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Antidiabetic Thiazolidinediones by Country

7.1.1 Europe Antidiabetic Thiazolidinediones Sales by Country (2017-2022)

7.1.2 Europe Antidiabetic Thiazolidinediones Revenue by Country (2017-2022)

7.2 Europe Antidiabetic Thiazolidinediones Sales by Type

7.3 Europe Antidiabetic Thiazolidinediones Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Antidiabetic Thiazolidinediones by Country

8.1.1 Middle East & Africa Antidiabetic Thiazolidinediones Sales by Country (2017-2022)

8.1.2 Middle East & Africa Antidiabetic Thiazolidinediones Revenue by Country (2017-2022)

8.2 Middle East & Africa Antidiabetic Thiazolidinediones Sales by Type

8.3 Middle East & Africa Antidiabetic Thiazolidinediones Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Antidiabetic Thiazolidinediones

10.3 Manufacturing Process Analysis of Antidiabetic Thiazolidinediones

10.4 Industry Chain Structure of Antidiabetic Thiazolidinediones

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Antidiabetic Thiazolidinediones Distributors

11.3 Antidiabetic Thiazolidinediones Customer

12 World Forecast Review for Antidiabetic Thiazolidinediones by Geographic Region

12.1 Global Antidiabetic Thiazolidinediones Market Size Forecast by Region

12.1.1 Global Antidiabetic Thiazolidinediones Forecast by Region (2023-2028)

12.1.2 Global Antidiabetic Thiazolidinediones Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Antidiabetic Thiazolidinediones Forecast by Type

12.7 Global Antidiabetic Thiazolidinediones Forecast by Application

13 Key Players Analysis

13.1 Sanofi

13.1.1 Sanofi Company Information

13.1.2 Sanofi Antidiabetic Thiazolidinediones Product Offered

13.1.3 Sanofi Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi Main Business Overview

13.1.5 Sanofi Latest Developments

13.2 Takeda Pharmaceuticals

13.2.1 Takeda Pharmaceuticals Company Information

13.2.2 Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Product Offered

13.2.3 Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Takeda Pharmaceuticals Main Business Overview

13.2.5 Takeda Pharmaceuticals Latest Developments

13.3 Eli Lilly

13.3.1 Eli Lilly Company Information

13.3.2 Eli Lilly Antidiabetic Thiazolidinediones Product Offered

13.3.3 Eli Lilly Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Eli Lilly Main Business Overview

13.3.5 Eli Lilly Latest Developments

13.4 Merck & Co.

13.4.1 Merck & Co. Company Information

13.4.2 Merck & Co. Antidiabetic Thiazolidinediones Product Offered

13.4.3 Merck & Co. Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Merck & Co. Main Business Overview

13.4.5 Merck & Co. Latest Developments

13.5 Novo Nordisk

13.5.1 Novo Nordisk Company Information

13.5.2 Novo Nordisk Antidiabetic Thiazolidinediones Product Offered

13.5.3 Novo Nordisk Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Novo Nordisk Main Business Overview

13.5.5 Novo Nordisk Latest Developments

13.6 Bristol-Myers Squibb

13.6.1 Bristol-Myers Squibb Company Information

13.6.2 Bristol-Myers Squibb Antidiabetic Thiazolidinediones Product Offered

13.6.3 Bristol-Myers Squibb Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Bristol-Myers Squibb Main Business Overview

13.6.5 Bristol-Myers Squibb Latest Developments

13.7 Pfizer

13.7.1 Pfizer Company Information

13.7.2 Pfizer Antidiabetic Thiazolidinediones Product Offered

13.7.3 Pfizer Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Pfizer Main Business Overview

13.7.5 Pfizer Latest Developments

13.8 AstraZeneca

13.8.1 AstraZeneca Company Information

13.8.2 AstraZeneca Antidiabetic Thiazolidinediones Product Offered

13.8.3 AstraZeneca Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 AstraZeneca Main Business Overview

13.8.5 AstraZeneca Latest Developments

13.9 GlaxoSmithKline

13.9.1 GlaxoSmithKline Company Information

13.9.2 GlaxoSmithKline Antidiabetic Thiazolidinediones Product Offered

13.9.3 GlaxoSmithKline Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 GlaxoSmithKline Main Business Overview

13.9.5 GlaxoSmithKline Latest Developments

13.10 Boehringer Ingelheim

13.10.1 Boehringer Ingelheim Company Information

13.10.2 Boehringer Ingelheim Antidiabetic Thiazolidinediones Product Offered

13.10.3 Boehringer Ingelheim Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Boehringer Ingelheim Main Business Overview

13.10.5 Boehringer Ingelheim Latest Developments

14 Research Findings and Conclusion

Table 1. Antidiabetic Thiazolidinediones Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Antidiabetic Thiazolidinediones Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Rosiglitazone

Table 4. Major Players of Pioglitazone

Table 5. Global Antidiabetic Thiazolidinediones Sales by Type (2017-2022) & (K Pcs)

Table 6. Global Antidiabetic Thiazolidinediones Sales Market Share by Type (2017-2022)

Table 7. Global Antidiabetic Thiazolidinediones Revenue by Type (2017-2022) & ($ million)

Table 8. Global Antidiabetic Thiazolidinediones Revenue Market Share by Type (2017-2022)

Table 9. Global Antidiabetic Thiazolidinediones Sale Price by Type (2017-2022) & (USD/Pcs)

Table 10. Global Antidiabetic Thiazolidinediones Sales by Application (2017-2022) & (K Pcs)

Table 11. Global Antidiabetic Thiazolidinediones Sales Market Share by Application (2017-2022)

Table 12. Global Antidiabetic Thiazolidinediones Revenue by Application (2017-2022)

Table 13. Global Antidiabetic Thiazolidinediones Revenue Market Share by Application (2017-2022)

Table 14. Global Antidiabetic Thiazolidinediones Sale Price by Application (2017-2022) & (USD/Pcs)

Table 15. Global Antidiabetic Thiazolidinediones Sales by Company (2020-2022) & (K Pcs)

Table 16. Global Antidiabetic Thiazolidinediones Sales Market Share by Company (2020-2022)

Table 17. Global Antidiabetic Thiazolidinediones Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Antidiabetic Thiazolidinediones Revenue Market Share by Company (2020-2022)

Table 19. Global Antidiabetic Thiazolidinediones Sale Price by Company (2020-2022) & (USD/Pcs)

Table 20. Key Manufacturers Antidiabetic Thiazolidinediones Producing Area Distribution and Sales Area

Table 21. Players Antidiabetic Thiazolidinediones Products Offered

Table 22. Antidiabetic Thiazolidinediones Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Antidiabetic Thiazolidinediones Sales by Geographic Region (2017-2022) & (K Pcs)

Table 26. Global Antidiabetic Thiazolidinediones Sales Market Share Geographic Region (2017-2022)

Table 27. Global Antidiabetic Thiazolidinediones Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Antidiabetic Thiazolidinediones Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Antidiabetic Thiazolidinediones Sales by Country/Region (2017-2022) & (K Pcs)

Table 30. Global Antidiabetic Thiazolidinediones Sales Market Share by Country/Region (2017-2022)

Table 31. Global Antidiabetic Thiazolidinediones Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Antidiabetic Thiazolidinediones Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Antidiabetic Thiazolidinediones Sales by Country (2017-2022) & (K Pcs)

Table 34. Americas Antidiabetic Thiazolidinediones Sales Market Share by Country (2017-2022)

Table 35. Americas Antidiabetic Thiazolidinediones Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Antidiabetic Thiazolidinediones Revenue Market Share by Country (2017-2022)

Table 37. Americas Antidiabetic Thiazolidinediones Sales by Type (2017-2022) & (K Pcs)

Table 38. Americas Antidiabetic Thiazolidinediones Sales Market Share by Type (2017-2022)

Table 39. Americas Antidiabetic Thiazolidinediones Sales by Application (2017-2022) & (K Pcs)

Table 40. Americas Antidiabetic Thiazolidinediones Sales Market Share by Application (2017-2022)

Table 41. APAC Antidiabetic Thiazolidinediones Sales by Region (2017-2022) & (K Pcs)

Table 42. APAC Antidiabetic Thiazolidinediones Sales Market Share by Region (2017-2022)

Table 43. APAC Antidiabetic Thiazolidinediones Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Antidiabetic Thiazolidinediones Revenue Market Share by Region (2017-2022)

Table 45. APAC Antidiabetic Thiazolidinediones Sales by Type (2017-2022) & (K Pcs)

Table 46. APAC Antidiabetic Thiazolidinediones Sales Market Share by Type (2017-2022)

Table 47. APAC Antidiabetic Thiazolidinediones Sales by Application (2017-2022) & (K Pcs)

Table 48. APAC Antidiabetic Thiazolidinediones Sales Market Share by Application (2017-2022)

Table 49. Europe Antidiabetic Thiazolidinediones Sales by Country (2017-2022) & (K Pcs)

Table 50. Europe Antidiabetic Thiazolidinediones Sales Market Share by Country (2017-2022)

Table 51. Europe Antidiabetic Thiazolidinediones Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Antidiabetic Thiazolidinediones Revenue Market Share by Country (2017-2022)

Table 53. Europe Antidiabetic Thiazolidinediones Sales by Type (2017-2022) & (K Pcs)

Table 54. Europe Antidiabetic Thiazolidinediones Sales Market Share by Type (2017-2022)

Table 55. Europe Antidiabetic Thiazolidinediones Sales by Application (2017-2022) & (K Pcs)

Table 56. Europe Antidiabetic Thiazolidinediones Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Antidiabetic Thiazolidinediones Sales by Country (2017-2022) & (K Pcs)

Table 58. Middle East & Africa Antidiabetic Thiazolidinediones Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Antidiabetic Thiazolidinediones Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Antidiabetic Thiazolidinediones Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Antidiabetic Thiazolidinediones Sales by Type (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Antidiabetic Thiazolidinediones Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Antidiabetic Thiazolidinediones Sales by Application (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Antidiabetic Thiazolidinediones Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Antidiabetic Thiazolidinediones

Table 66. Key Market Challenges & Risks of Antidiabetic Thiazolidinediones

Table 67. Key Industry Trends of Antidiabetic Thiazolidinediones

Table 68. Antidiabetic Thiazolidinediones Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Antidiabetic Thiazolidinediones Distributors List

Table 71. Antidiabetic Thiazolidinediones Customer List

Table 72. Global Antidiabetic Thiazolidinediones Sales Forecast by Region (2023-2028) & (K Pcs)

Table 73. Global Antidiabetic Thiazolidinediones Sales Market Forecast by Region

Table 74. Global Antidiabetic Thiazolidinediones Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Antidiabetic Thiazolidinediones Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Antidiabetic Thiazolidinediones Sales Forecast by Country (2023-2028) & (K Pcs)

Table 77. Americas Antidiabetic Thiazolidinediones Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Antidiabetic Thiazolidinediones Sales Forecast by Region (2023-2028) & (K Pcs)

Table 79. APAC Antidiabetic Thiazolidinediones Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Antidiabetic Thiazolidinediones Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Europe Antidiabetic Thiazolidinediones Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Antidiabetic Thiazolidinediones Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Middle East & Africa Antidiabetic Thiazolidinediones Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Antidiabetic Thiazolidinediones Sales Forecast by Type (2023-2028) & (K Pcs)

Table 85. Global Antidiabetic Thiazolidinediones Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Antidiabetic Thiazolidinediones Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Antidiabetic Thiazolidinediones Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Antidiabetic Thiazolidinediones Sales Forecast by Application (2023-2028) & (K Pcs)

Table 89. Global Antidiabetic Thiazolidinediones Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Antidiabetic Thiazolidinediones Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Antidiabetic Thiazolidinediones Revenue Market Share Forecast by Application (2023-2028)

Table 92. Sanofi Basic Information, Antidiabetic Thiazolidinediones Manufacturing Base, Sales Area and Its Competitors

Table 93. Sanofi Antidiabetic Thiazolidinediones Product Offered

Table 94. Sanofi Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 95. Sanofi Main Business

Table 96. Sanofi Latest Developments

Table 97. Takeda Pharmaceuticals Basic Information, Antidiabetic Thiazolidinediones Manufacturing Base, Sales Area and Its Competitors

Table 98. Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Product Offered

Table 99. Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 100. Takeda Pharmaceuticals Main Business

Table 101. Takeda Pharmaceuticals Latest Developments

Table 102. Eli Lilly Basic Information, Antidiabetic Thiazolidinediones Manufacturing Base, Sales Area and Its Competitors

Table 103. Eli Lilly Antidiabetic Thiazolidinediones Product Offered

Table 104. Eli Lilly Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 105. Eli Lilly Main Business

Table 106. Eli Lilly Latest Developments

Table 107. Merck & Co. Basic Information, Antidiabetic Thiazolidinediones Manufacturing Base, Sales Area and Its Competitors

Table 108. Merck & Co. Antidiabetic Thiazolidinediones Product Offered

Table 109. Merck & Co. Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 110. Merck & Co. Main Business

Table 111. Merck & Co. Latest Developments

Table 112. Novo Nordisk Basic Information, Antidiabetic Thiazolidinediones Manufacturing Base, Sales Area and Its Competitors

Table 113. Novo Nordisk Antidiabetic Thiazolidinediones Product Offered

Table 114. Novo Nordisk Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 115. Novo Nordisk Main Business

Table 116. Novo Nordisk Latest Developments

Table 117. Bristol-Myers Squibb Basic Information, Antidiabetic Thiazolidinediones Manufacturing Base, Sales Area and Its Competitors

Table 118. Bristol-Myers Squibb Antidiabetic Thiazolidinediones Product Offered

Table 119. Bristol-Myers Squibb Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 120. Bristol-Myers Squibb Main Business

Table 121. Bristol-Myers Squibb Latest Developments

Table 122. Pfizer Basic Information, Antidiabetic Thiazolidinediones Manufacturing Base, Sales Area and Its Competitors

Table 123. Pfizer Antidiabetic Thiazolidinediones Product Offered

Table 124. Pfizer Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 125. Pfizer Main Business

Table 126. Pfizer Latest Developments

Table 127. AstraZeneca Basic Information, Antidiabetic Thiazolidinediones Manufacturing Base, Sales Area and Its Competitors

Table 128. AstraZeneca Antidiabetic Thiazolidinediones Product Offered

Table 129. AstraZeneca Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 130. AstraZeneca Main Business

Table 131. AstraZeneca Latest Developments

Table 132. GlaxoSmithKline Basic Information, Antidiabetic Thiazolidinediones Manufacturing Base, Sales Area and Its Competitors

Table 133. GlaxoSmithKline Antidiabetic Thiazolidinediones Product Offered

Table 134. GlaxoSmithKline Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 135. GlaxoSmithKline Main Business

Table 136. GlaxoSmithKline Latest Developments

Table 137. Boehringer Ingelheim Basic Information, Antidiabetic Thiazolidinediones Manufacturing Base, Sales Area and Its Competitors

Table 138. Boehringer Ingelheim Antidiabetic Thiazolidinediones Product Offered

Table 139. Boehringer Ingelheim Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 140. Boehringer Ingelheim Main Business

Table 141. Boehringer Ingelheim Latest Developments

List of Figures

Figure 1. Picture of Antidiabetic Thiazolidinediones

Figure 2. Antidiabetic Thiazolidinediones Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Antidiabetic Thiazolidinediones Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Antidiabetic Thiazolidinediones Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Antidiabetic Thiazolidinediones Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Rosiglitazone

Figure 10. Product Picture of Pioglitazone

Figure 11. Global Antidiabetic Thiazolidinediones Sales Market Share by Type in 2021

Figure 12. Global Antidiabetic Thiazolidinediones Revenue Market Share by Type (2017-2022)

Figure 13. Antidiabetic Thiazolidinediones Consumed in Hospitals

Figure 14. Global Antidiabetic Thiazolidinediones Market: Hospitals (2017-2022) & (K Pcs)

Figure 15. Antidiabetic Thiazolidinediones Consumed in Clinics

Figure 16. Global Antidiabetic Thiazolidinediones Market: Clinics (2017-2022) & (K Pcs)

Figure 17. Antidiabetic Thiazolidinediones Consumed in Other

Figure 18. Global Antidiabetic Thiazolidinediones Market: Other (2017-2022) & (K Pcs)

Figure 19. Global Antidiabetic Thiazolidinediones Sales Market Share by Application (2017-2022)

Figure 20. Global Antidiabetic Thiazolidinediones Revenue Market Share by Application in 2021

Figure 21. Antidiabetic Thiazolidinediones Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Antidiabetic Thiazolidinediones Revenue Market Share by Company in 2021

Figure 23. Global Antidiabetic Thiazolidinediones Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Antidiabetic Thiazolidinediones Revenue Market Share by Geographic Region in 2021

Figure 25. Global Antidiabetic Thiazolidinediones Sales Market Share by Region (2017-2022)

Figure 26. Global Antidiabetic Thiazolidinediones Revenue Market Share by Country/Region in 2021

Figure 27. Americas Antidiabetic Thiazolidinediones Sales 2017-2022 (K Pcs)

Figure 28. Americas Antidiabetic Thiazolidinediones Revenue 2017-2022 ($ Millions)

Figure 29. APAC Antidiabetic Thiazolidinediones Sales 2017-2022 (K Pcs)

Figure 30. APAC Antidiabetic Thiazolidinediones Revenue 2017-2022 ($ Millions)

Figure 31. Europe Antidiabetic Thiazolidinediones Sales 2017-2022 (K Pcs)

Figure 32. Europe Antidiabetic Thiazolidinediones Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Antidiabetic Thiazolidinediones Sales 2017-2022 (K Pcs)

Figure 34. Middle East & Africa Antidiabetic Thiazolidinediones Revenue 2017-2022 ($ Millions)

Figure 35. Americas Antidiabetic Thiazolidinediones Sales Market Share by Country in 2021

Figure 36. Americas Antidiabetic Thiazolidinediones Revenue Market Share by Country in 2021

Figure 37. United States Antidiabetic Thiazolidinediones Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Antidiabetic Thiazolidinediones Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Antidiabetic Thiazolidinediones Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Antidiabetic Thiazolidinediones Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Antidiabetic Thiazolidinediones Sales Market Share by Region in 2021

Figure 42. APAC Antidiabetic Thiazolidinediones Revenue Market Share by Regions in 2021

Figure 43. China Antidiabetic Thiazolidinediones Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Antidiabetic Thiazolidinediones Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Antidiabetic Thiazolidinediones Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Antidiabetic Thiazolidinediones Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Antidiabetic Thiazolidinediones Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Antidiabetic Thiazolidinediones Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Antidiabetic Thiazolidinediones Sales Market Share by Country in 2021

Figure 50. Europe Antidiabetic Thiazolidinediones Revenue Market Share by Country in 2021

Figure 51. Germany Antidiabetic Thiazolidinediones Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Antidiabetic Thiazolidinediones Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Antidiabetic Thiazolidinediones Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Antidiabetic Thiazolidinediones Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Antidiabetic Thiazolidinediones Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Antidiabetic Thiazolidinediones Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Antidiabetic Thiazolidinediones Revenue Market Share by Country in 2021

Figure 58. Egypt Antidiabetic Thiazolidinediones Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Antidiabetic Thiazolidinediones Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Antidiabetic Thiazolidinediones Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Antidiabetic Thiazolidinediones Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Antidiabetic Thiazolidinediones Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Antidiabetic Thiazolidinediones in 2021

Figure 64. Manufacturing Process Analysis of Antidiabetic Thiazolidinediones

Figure 65. Industry Chain Structure of Antidiabetic Thiazolidinediones

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles